Hospital Infection Therapeutics Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Infection Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Antibacterial Drugs
1.2.3 Antiviral Drugs
1.2.4 Antifungal Drugs
1.3 Market by Application
1.3.1 Global Hospital Infection Therapeutics Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospital Acquired Pneumonia
1.3.3 Surgical Site Infections
1.3.4 Urinary Tract Infection
1.3.5 Gastrointestinal Disorders
1.3.6 Bloodstream Infections
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital Infection Therapeutics Market Perspective (2018-2030)
2.2 Hospital Infection Therapeutics Growth Trends by Region
2.2.1 Hospital Infection Therapeutics Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Hospital Infection Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Hospital Infection Therapeutics Forecasted Market Size by Region (2023-2030)
2.3 Hospital Infection Therapeutics Market Dynamics
2.3.1 Hospital Infection Therapeutics Industry Trends
2.3.2 Hospital Infection Therapeutics Market Drivers
2.3.3 Hospital Infection Therapeutics Market Challenges
2.3.4 Hospital Infection Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Infection Therapeutics Players by Revenue
3.1.1 Global Top Hospital Infection Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Hospital Infection Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Hospital Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Infection Therapeutics Revenue
3.4 Global Hospital Infection Therapeutics Market Concentration Ratio
3.4.1 Global Hospital Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Infection Therapeutics Revenue in 2022
3.5 Hospital Infection Therapeutics Key Players Head office and Area Served
3.6 Key Players Hospital Infection Therapeutics Product Solution and Service
3.7 Date of Enter into Hospital Infection Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Infection Therapeutics Breakdown Data by Type
4.1 Global Hospital Infection Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Hospital Infection Therapeutics Forecasted Market Size by Type (2023-2030)
5 Hospital Infection Therapeutics Breakdown Data by Application
5.1 Global Hospital Infection Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Hospital Infection Therapeutics Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Hospital Infection Therapeutics Market Size (2018-2030)
6.2 North America Hospital Infection Therapeutics Market Size by Country (2018-2023)
6.3 North America Hospital Infection Therapeutics Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Hospital Infection Therapeutics Market Size (2018-2030)
7.2 Europe Hospital Infection Therapeutics Market Size by Country (2018-2023)
7.3 Europe Hospital Infection Therapeutics Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Infection Therapeutics Market Size (2018-2030)
8.2 Asia-Pacific Hospital Infection Therapeutics Market Size by Country (2018-2023)
8.3 Asia-Pacific Hospital Infection Therapeutics Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Hospital Infection Therapeutics Market Size (2018-2030)
9.2 Latin America Hospital Infection Therapeutics Market Size by Country (2018-2023)
9.3 Latin America Hospital Infection Therapeutics Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Infection Therapeutics Market Size (2018-2030)
10.2 Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2018-2023)
10.3 Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Hospital Infection Therapeutics Introduction
11.1.4 Bayer Revenue in Hospital Infection Therapeutics Business (2018-2023)
11.1.5 Bayer Recent Development
11.2 Johnson & Johnson Services
11.2.1 Johnson & Johnson Services Company Detail
11.2.2 Johnson & Johnson Services Business Overview
11.2.3 Johnson & Johnson Services Hospital Infection Therapeutics Introduction
11.2.4 Johnson & Johnson Services Revenue in Hospital Infection Therapeutics Business (2018-2023)
11.2.5 Johnson & Johnson Services Recent Development
11.3 Actavis
11.3.1 Actavis Company Detail
11.3.2 Actavis Business Overview
11.3.3 Actavis Hospital Infection Therapeutics Introduction
11.3.4 Actavis Revenue in Hospital Infection Therapeutics Business (2018-2023)
11.3.5 Actavis Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Hospital Infection Therapeutics Introduction
11.4.4 Sanofi Revenue in Hospital Infection Therapeutics Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 Bristol Myers Squibb Company
11.5.1 Bristol Myers Squibb Company Company Detail
11.5.2 Bristol Myers Squibb Company Business Overview
11.5.3 Bristol Myers Squibb Company Hospital Infection Therapeutics Introduction
11.5.4 Bristol Myers Squibb Company Revenue in Hospital Infection Therapeutics Business (2018-2023)
11.5.5 Bristol Myers Squibb Company Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Hospital Infection Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Hospital Infection Therapeutics Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Hospital Infection Therapeutics Introduction
11.7.4 Pfizer Revenue in Hospital Infection Therapeutics Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Hospital Infection Therapeutics Introduction
11.8.4 Merck Revenue in Hospital Infection Therapeutics Business (2018-2023)
11.8.5 Merck Recent Development
11.9 GlaxoSmithkline
11.9.1 GlaxoSmithkline Company Detail
11.9.2 GlaxoSmithkline Business Overview
11.9.3 GlaxoSmithkline Hospital Infection Therapeutics Introduction
11.9.4 GlaxoSmithkline Revenue in Hospital Infection Therapeutics Business (2018-2023)
11.9.5 GlaxoSmithkline Recent Development
11.10 Cubist Pharmaceuticals
11.10.1 Cubist Pharmaceuticals Company Detail
11.10.2 Cubist Pharmaceuticals Business Overview
11.10.3 Cubist Pharmaceuticals Hospital Infection Therapeutics Introduction
11.10.4 Cubist Pharmaceuticals Revenue in Hospital Infection Therapeutics Business (2018-2023)
11.10.5 Cubist Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Hospital Infection Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2030
Table 2. Key Players of Antibacterial Drugs
Table 3. Key Players of Antiviral Drugs
Table 4. Key Players of Antifungal Drugs
Table 5. Global Hospital Infection Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2030
Table 6. Global Hospital Infection Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2030
Table 7. Global Hospital Infection Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Hospital Infection Therapeutics Market Share by Region (2018-2023)
Table 9. Global Hospital Infection Therapeutics Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 10. Global Hospital Infection Therapeutics Market Share by Region (2023-2030)
Table 11. Hospital Infection Therapeutics Market Trends
Table 12. Hospital Infection Therapeutics Market Drivers
Table 13. Hospital Infection Therapeutics Market Challenges
Table 14. Hospital Infection Therapeutics Market Restraints
Table 15. Global Hospital Infection Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Hospital Infection Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top Hospital Infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Infection Therapeutics as of 2022)
Table 18. Ranking of Global Top Hospital Infection Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Hospital Infection Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hospital Infection Therapeutics Product Solution and Service
Table 22. Date of Enter into Hospital Infection Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hospital Infection Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Hospital Infection Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Hospital Infection Therapeutics Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 27. Global Hospital Infection Therapeutics Revenue Market Share by Type (2023-2030)
Table 28. Global Hospital Infection Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Hospital Infection Therapeutics Revenue Market Share by Application (2018-2023)
Table 30. Global Hospital Infection Therapeutics Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 31. Global Hospital Infection Therapeutics Revenue Market Share by Application (2023-2030)
Table 32. North America Hospital Infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Hospital Infection Therapeutics Market Size by Country (2023-2030) & (US$ Million)
Table 34. Europe Hospital Infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Hospital Infection Therapeutics Market Size by Country (2023-2030) & (US$ Million)
Table 36. Asia-Pacific Hospital Infection Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 37. Asia-Pacific Hospital Infection Therapeutics Market Size by Region (2023-2030) & (US$ Million)
Table 38. Latin America Hospital Infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Latin America Hospital Infection Therapeutics Market Size by Country (2023-2030) & (US$ Million)
Table 40. Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2023-2030) & (US$ Million)
Table 42. Bayer Company Detail
Table 43. Bayer Business Overview
Table 44. Bayer Hospital Infection Therapeutics Product
Table 45. Bayer Revenue in Hospital Infection Therapeutics Business (2018-2023) & (US$ Million)
Table 46. Bayer Recent Development
Table 47. Johnson & Johnson Services Company Detail
Table 48. Johnson & Johnson Services Business Overview
Table 49. Johnson & Johnson Services Hospital Infection Therapeutics Product
Table 50. Johnson & Johnson Services Revenue in Hospital Infection Therapeutics Business (2018-2023) & (US$ Million)
Table 51. Johnson & Johnson Services Recent Development
Table 52. Actavis Company Detail
Table 53. Actavis Business Overview
Table 54. Actavis Hospital Infection Therapeutics Product
Table 55. Actavis Revenue in Hospital Infection Therapeutics Business (2018-2023) & (US$ Million)
Table 56. Actavis Recent Development
Table 57. Sanofi Company Detail
Table 58. Sanofi Business Overview
Table 59. Sanofi Hospital Infection Therapeutics Product
Table 60. Sanofi Revenue in Hospital Infection Therapeutics Business (2018-2023) & (US$ Million)
Table 61. Sanofi Recent Development
Table 62. Bristol Myers Squibb Company Company Detail
Table 63. Bristol Myers Squibb Company Business Overview
Table 64. Bristol Myers Squibb Company Hospital Infection Therapeutics Product
Table 65. Bristol Myers Squibb Company Revenue in Hospital Infection Therapeutics Business (2018-2023) & (US$ Million)
Table 66. Bristol Myers Squibb Company Recent Development
Table 67. AstraZeneca Company Detail
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Hospital Infection Therapeutics Product
Table 70. AstraZeneca Revenue in Hospital Infection Therapeutics Business (2018-2023) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Pfizer Company Detail
Table 73. Pfizer Business Overview
Table 74. Pfizer Hospital Infection Therapeutics Product
Table 75. Pfizer Revenue in Hospital Infection Therapeutics Business (2018-2023) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Merck Company Detail
Table 78. Merck Business Overview
Table 79. Merck Hospital Infection Therapeutics Product
Table 80. Merck Revenue in Hospital Infection Therapeutics Business (2018-2023) & (US$ Million)
Table 81. Merck Recent Development
Table 82. GlaxoSmithkline Company Detail
Table 83. GlaxoSmithkline Business Overview
Table 84. GlaxoSmithkline Hospital Infection Therapeutics Product
Table 85. GlaxoSmithkline Revenue in Hospital Infection Therapeutics Business (2018-2023) & (US$ Million)
Table 86. GlaxoSmithkline Recent Development
Table 87. Cubist Pharmaceuticals Company Detail
Table 88. Cubist Pharmaceuticals Business Overview
Table 89. Cubist Pharmaceuticals Hospital Infection Therapeutics Product
Table 90. Cubist Pharmaceuticals Revenue in Hospital Infection Therapeutics Business (2018-2023) & (US$ Million)
Table 91. Cubist Pharmaceuticals Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Infection Therapeutics Market Share by Type: 2022 VS 2030
Figure 2. Antibacterial Drugs Features
Figure 3. Antiviral Drugs Features
Figure 4. Antifungal Drugs Features
Figure 5. Global Hospital Infection Therapeutics Market Share by Application in 2022 & 2030
Figure 6. Hospital Acquired Pneumonia Case Studies
Figure 7. Surgical Site Infections Case Studies
Figure 8. Urinary Tract Infection Case Studies
Figure 9. Gastrointestinal Disorders Case Studies
Figure 10. Bloodstream Infections Case Studies
Figure 11. Others Case Studies
Figure 12. Hospital Infection Therapeutics Report Years Considered
Figure 13. Global Hospital Infection Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2030
Figure 14. Global Hospital Infection Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2030
Figure 15. Global Hospital Infection Therapeutics Market Share by Region: 2022 VS 2030
Figure 16. Global Hospital Infection Therapeutics Market Share by Players in 2022
Figure 17. Global Top Hospital Infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Infection Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Hospital Infection Therapeutics Revenue in 2022
Figure 19. North America Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 20. North America Hospital Infection Therapeutics Market Share by Country (2018-2030)
Figure 21. United States Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 22. Canada Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 23. Europe Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 24. Europe Hospital Infection Therapeutics Market Share by Country (2018-2030)
Figure 25. Germany Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 26. France Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 27. U.K. Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 28. Italy Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 29. Russia Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 30. Nordic Countries Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 31. Asia-Pacific Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 32. Asia-Pacific Hospital Infection Therapeutics Market Share by Region (2018-2030)
Figure 33. China Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 34. Japan Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 35. South Korea Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 36. Southeast Asia Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 37. India Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 38. Australia Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 39. Latin America Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 40. Latin America Hospital Infection Therapeutics Market Share by Country (2018-2030)
Figure 41. Mexico Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 42. Brazil Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 43. Middle East & Africa Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 44. Middle East & Africa Hospital Infection Therapeutics Market Share by Country (2018-2030)
Figure 45. Turkey Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 46. Saudi Arabia Hospital Infection Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 47. Bayer Revenue Growth Rate in Hospital Infection Therapeutics Business (2018-2023)
Figure 48. Johnson & Johnson Services Revenue Growth Rate in Hospital Infection Therapeutics Business (2018-2023)
Figure 49. Actavis Revenue Growth Rate in Hospital Infection Therapeutics Business (2018-2023)
Figure 50. Sanofi Revenue Growth Rate in Hospital Infection Therapeutics Business (2018-2023)
Figure 51. Bristol Myers Squibb Company Revenue Growth Rate in Hospital Infection Therapeutics Business (2018-2023)
Figure 52. AstraZeneca Revenue Growth Rate in Hospital Infection Therapeutics Business (2018-2023)
Figure 53. Pfizer Revenue Growth Rate in Hospital Infection Therapeutics Business (2018-2023)
Figure 54. Merck Revenue Growth Rate in Hospital Infection Therapeutics Business (2018-2023)
Figure 55. GlaxoSmithkline Revenue Growth Rate in Hospital Infection Therapeutics Business (2018-2023)
Figure 56. Cubist Pharmaceuticals Revenue Growth Rate in Hospital Infection Therapeutics Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Industry Market Size
